---
title: "港股收盘，恒指收跌 2.09%，科指收跌 2.63%。汽车股、内房股走低，龙湖集团跌超 7%，小鹏汽车跌近 6%。"
description: "港股收盘，恒指收跌 2.09%，科指收跌 2.63%。汽车股、内房股走低，龙湖集团跌超 7%，小鹏汽车跌近 6%。"
type: "news"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/news/222247412.md"
published_at: "2024-12-13T08:08:50.000Z"
---

# 港股收盘，恒指收跌 2.09%，科指收跌 2.63%。汽车股、内房股走低，龙湖集团跌超 7%，小鹏汽车跌近 6%。

港股收盘，恒指收跌 2.09%，科指收跌 2.63%。汽车股、内房股走低，龙湖集团 (00960.HK) 跌超 7%，小鹏汽车 (09868.HK) 跌近 6%。

### Related Stocks

- [XPEV.US - 小鹏汽车](https://longbridge.com/zh-CN/quote/XPEV.US.md)
- [09868.HK - 小鹏汽车-W](https://longbridge.com/zh-CN/quote/09868.HK.md)
- [00960.HK - 龙湖集团](https://longbridge.com/zh-CN/quote/00960.HK.md)
- [02800.HK - 盈富基金](https://longbridge.com/zh-CN/quote/02800.HK.md)
- [07300.HK - 南方一倍看空恒指](https://longbridge.com/zh-CN/quote/07300.HK.md)
- [07200.HK - 南方两倍看多恒指](https://longbridge.com/zh-CN/quote/07200.HK.md)
- [82800.HK - 盈富基金-R](https://longbridge.com/zh-CN/quote/82800.HK.md)
- [00HSI.HK - 恒生指数](https://longbridge.com/zh-CN/quote/00HSI.HK.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| Nomura Adjusts CSPC Pharmaceutical Group's Price Target to HK$12.04 From HK$9.11, Keeps at Buy | Nomura Adjusts CSPC Pharmaceutical Group's Price Target to HK$12.04 From HK$9.11, Keeps at Buy | [Link](https://longbridge.com/zh-CN/news/276056763.md) |
| Trump's affordability agenda has a car problem it needs to fix | The Trump administration's affordability agenda overlooks the auto market, which is crucial for American families. A rec | [Link](https://longbridge.com/zh-CN/news/275946150.md) |
| Nomura Upgrades China Literature to Buy From Neutral, Adjusts Price Target to HK$47 From HK$33 | Nomura Upgrades China Literature to Buy From Neutral, Adjusts Price Target to HK$47 From HK$33 | [Link](https://longbridge.com/zh-CN/news/275882954.md) |
| CSPC Pharmaceutical says ropivacaine long-acting injection approved for clinical trials in China | CSPC Pharmaceutical says ropivacaine long-acting injection approved for clinical trials in China | [Link](https://longbridge.com/zh-CN/news/276051793.md) |
| CSPC Pharmaceutical Receives Regulatory Nods to Begin Drug Trials | CSPC Pharmaceutical Receives Regulatory Nods to Begin Drug Trials | [Link](https://longbridge.com/zh-CN/news/276035104.md) |

---

> **免责声明**：本文内容仅供参考，不构成任何投资建议。